SOL Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,990
| Closed | -$291K | – | 237 |
|
|
2020
Q4 | $291K | Sell |
4,990
-50
| -1% | -$2.92K | 0.07% | 200 |
|
|
2020
Q3 | $318K | Sell |
5,040
-250
| -5% | -$15.8K | 0.09% | 180 |
|
|
2020
Q2 | $407K | Buy |
5,290
+220
| +4% | +$16.9K | 0.12% | 155 |
|
|
2020
Q1 | $379K | Sell |
5,070
-500
| -9% | -$37.4K | 0.13% | 156 |
|
|
2019
Q4 | $362K | Sell |
5,570
-4,550
| -45% | -$296K | 0.09% | 184 |
|
|
2019
Q3 | $641K | Sell |
10,120
-876
| -8% | -$55.5K | 0.18% | 131 |
|
|
2019
Q2 | $743K | Sell |
10,996
-1,900
| -15% | -$128K | 0.2% | 126 |
|
|
2019
Q1 | $838K | Buy |
12,896
+250
| +2% | +$16.2K | 0.23% | 111 |
|
|
2018
Q4 | $791K | Hold |
12,646
| – | – | 0.25% | 108 |
|
|
2018
Q3 | $976K | Buy |
12,646
+400
| +3% | +$30.9K | 0.26% | 104 |
|
|
2018
Q2 | $868K | Buy |
12,246
+1,526
| +14% | +$108K | 0.25% | 105 |
|
|
2018
Q1 | $808K | Buy |
10,720
+550
| +5% | +$41.5K | 0.23% | 111 |
|
|
2017
Q4 | $729K | Sell |
10,170
-600
| -6% | -$43K | 0.21% | 115 |
|
|
2017
Q3 | $873K | Buy |
10,770
+750
| +7% | +$60.8K | 0.25% | 105 |
|
|
2017
Q2 | $709K | Buy |
10,020
+1,120
| +13% | +$79.3K | 0.19% | 123 |
|
|
2017
Q1 | $604K | Buy |
8,900
+2,375
| +36% | +$161K | 0.17% | 125 |
|
|
2016
Q4 | $467K | Buy |
6,525
+3,965
| +155% | +$284K | 0.14% | 141 |
|
|
2016
Q3 | $203K | Buy |
+2,560
| New | +$203K | 0.07% | 209 |
|